Session Information
2007 BIO International Convention
Click here to go to the previous page
Corporate Life Cycle and Portfolio Management for Investors
Track : Public Relations/Investor Relations
Program Code: PUB050
Date: Wednesday, May 9, 2007
Time: 9:15 AM to 10:45 AM  
Location: 205 C
CHAIR :
Peter Kellogg, Chief Financial Officer, BiogenIdec
SPEAKER (S):
Karen Bergman
Sally Curley
Stephen Potter, Senior Vice President, Corporate Development, Genzyme Corporation
Howard (Howie) Rosen, Vice President, Commercial Strategy, Gilead Sciences, Inc.
David Sobell, Senior Research Analyst, Pioneer Investments
Description
This panel will review everything from dashboard and corporate performance analysis techniques to investor relations scenarios to demonstrate the need for cross-fertilization between strategic planning, business development, finance and investor relations. Learn how effective interaction between these groups can improve the strategic planning process, support M&A outcomes and product licensing efforts, which may lead to increased corporate value, access to capital markets and shareholder communications.



Objectives:
  • Learn which information and tools are critical to a comprehensive and successful portfolio management outcome.

  • Discuss which groups may be most beneficial to the collaborative process, and learn why those groups should be involved from the onset.

  • Leave with case studies and best practice scenarios to guide you in the future.


  • Streaming Audio with
    PowerPoint Slides
    (Code: PUB050)
      
    This session is a part of: